<DOC>
	<DOCNO>NCT01462851</DOCNO>
	<brief_summary>This study design observe safety concentration PF-05297909 protein blood cerebrospinal fluid single dose PF-05297909 healthy adult .</brief_summary>
	<brief_title>A Study To Observe Safety And Concentrations Of PF-05297909 And Proteins In Both Blood And Cerebrospinal Fluid After A Single Dose Of PF-05297909 In Healthy Adults</brief_title>
	<detailed_description />
	<criteria>For Healthy adult volunteer : healthy male and/or female subject non child bear potential age 18 55 year , inclusive . ( Healthy define clinically relevant abnormality identify detailed medical history , full physical examination , include blood pressure heart rate measurement , 12 lead ECG clinical laboratory test . ) Evidence history clinically significant hematological , renal , endocrine , pulmonary , gastrointestinal , cardiovascular , hepatic , psychiatric , neurologic , allergic disease ( include drug allergy , exclude untreated , asymptomatic , seasonal allergy time dose )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>healthy volunteer</keyword>
	<keyword>safety</keyword>
	<keyword>pharmacokinetic</keyword>
	<keyword>pharmacodynamic</keyword>
</DOC>